Novartis AG
NYSENVS short interest surges 46% in one day to 5.2 million shares, though availability remains ample at 476% and borrow costs stay subdued at 0.98%.
A new long-form analysis for NVS this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumNo long-form analysis yet for NVS. Pulse alerts and the live data picture are available on ORTEX.
Open NVS on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NVS — free to start on ORTEX.
Sign up for free →Open NVS on ORTEXSnapshot as of 28 Jun 2026
Pulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live NVS data →